Malakoff Humanis Investissements Privés

Malakoff Humanis Investissements Privés

Malakoff Humanis Investissements Privés operates as the dedicated investment vehicle for Groupe Malakoff Humanis, the product of a 2019 merger that created a dominant force in French social protection. The group manages complementary health and retirement schemes for over 400,000 corporate clients, generating substantial institutional inflows that the investment arm must steward across decades-long liability horizons. Its governance reflects a paritarian model — employer and employee representatives share oversight — which embeds a preference for tangibility and social utility into portfolio construction. Historical leadership under founding CEO Jean-Yves Mary anchored the unit within a network of specialist co-investment partners. The portfolio demonstrates a distinct tilt toward French real assets and financial infrastructure. On the direct real estate side, known holdings include SC Puccini at 21 rue Laffitte in the 9th arrondissement, the SCI Alliance Parc A10 industrial portfolio, Babylone SAS at 30 rue des Mathurins, and interests in the OPCI Vivaldi commercial vehicle. In venture, the firm launched MH Innov' 1, a dedicated fund co-invested alongside Elaia Partners to back French deep tech and digital startups. A subsequent collaboration with Mandalore Partners targeted fintech exposure through the acquisition of neo-broker Mon Petit Placement. The group also held a significant, long-dated stake in LBP AM, the asset manager of La Banque Postale, cementing its role as a keystone investor in French financial ecosystems. The firm executed a strategic pivot in 2022 by selling its broader asset management subsidiary to Sienna Investment Managers, a move that transformed Malakoff Humanis from a multi-strategy manager into a pure asset-owner focused on selecting and monitoring external managers and direct holdings. This transaction concentrated the investment team’s effort on internal real estate portfolios, co-investment fund structures, and partnership oversight. The group also channels social-impact capital through two specialized foundations: Fondation Malakoff Humanis Handicap, focused on disability inclusion, and Fondation Médéric Alzheimer, which funds research into neurodegenerative disease. The sale to Sienna Investment Managers marks the fundamental structural differentiator. Most French insurance groups build captive management companies and keep them indefinitely; Malakoff Humanis chose to unbundle, retaining only the private-markets and real-asset selection functions. That makes the entity now resemble a specialized in-house allocator — an investment office inside a mutual insurer — with a concentrated book of direct Paris real estate, niche venture partnerships, and legacy financial infrastructure stakes that few peers replicate at this scale.